in Denmark, Finland, Norway, and Sweden; both first and second doses of mRNA vaccines were associated with increased risk of myocarditis and pericarditis; highest in males 16-24, post 2nd dose.
SOURCE: https://jamanetwork.com/journals/jamacardiology/fullarticle/2791253